blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3744726

EP3744726 - NOVEL NUCLEOSIDE OR NUCLEOTIDE DERIVATIVES, AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  30.10.2020
Database last updated on 14.06.2024
FormerThe international publication has been made
Status updated on  03.08.2019
Most recent event   Tooltip29.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
ST Pharm Co., Ltd.
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
[2020/49]
Inventor(s)01 / KIM, Kyungjin
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
02 / KIM, Meehyein
205-303, 127 Dunsannam-ro Seo-gu
Daejeon 35249 / KR
03 / KIM, Uk-Il
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
04 / GO, Yun Young
108-405, 43, Gajeong-ro Yuseong-gu
Daejeon 34118 / KR
05 / NAM, Hwajung
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
06 / BANG, Hyung Tae
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
07 / SHIN, Jin Soo
109-802, 14 Noeul 3-ro
Sejong 30130 / KR
08 / YOON, Jihye
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
09 / JANG, Yejin
160, Dongchundang-ro, Daedeok-gu
Daejeon 34399 / KR
 [2020/49]
Representative(s)Hoppe, Georg Johannes
Darani Anwaltskanzlei
Hohenzollerndamm 117
14199 Berlin / DE
[N/P]
Former [2020/49]Hoppe, Georg Johannes
Darani Anwaltskanzlei
Beuckestrasse 20
14163 Berlin / DE
Application number, filing date19743401.224.01.2019
[2020/49]
WO2019KR01036
Priority number, dateKR2018000900924.01.2018         Original published format: KR 20180009009
[2020/49]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019147050
Date:01.08.2019
Language:KO
[2019/31]
Type: A1 Application with search report 
No.:EP3744726
Date:02.12.2020
Language:EN
[2020/49]
Search report(s)International search report - published on:KR01.08.2019
(Supplementary) European search report - dispatched on:EP23.12.2021
ClassificationIPC:C07H19/06, C07H19/10, C07H19/073, A61P31/12, A61P31/18, A61P31/16
[2021/45]
CPC:
C07H19/073 (EP); C07H19/067 (KR,US); A61P31/12 (EP,KR);
A61P31/16 (EP,KR); A61P31/18 (EP,KR); C07H19/06 (EP);
C07H19/10 (EP) (-)
Former IPC [2020/49]C07H19/067, A61P31/12, A61P31/18, A61P31/16
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/49]
TitleGerman:NEUE NUKLEOSID- ODER NUKLEOTIDDERIVATE UND IHRE VERWENDUNGEN[2020/49]
English:NOVEL NUCLEOSIDE OR NUCLEOTIDE DERIVATIVES, AND USES THEREOF[2020/49]
French:NOUVEAUX DÉRIVÉS DE NUCLÉOSIDE OU DE NUCLÉOTIDE, ET LEURS UTILISATIONS[2020/49]
Entry into regional phase13.08.2020Translation filed 
13.08.2020National basic fee paid 
13.08.2020Search fee paid 
13.08.2020Designation fee(s) paid 
13.08.2020Examination fee paid 
Examination procedure13.08.2020Examination requested  [2020/49]
22.07.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
21.01.2021Renewal fee patent year 03
24.01.2022Renewal fee patent year 04
23.01.2023Renewal fee patent year 05
29.01.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]CN101781283  (HUIHUI ZENG) [X] 1,2 * page 3; compound 10 *;
 [X]WO2015066053  (SYNTA PHARMACEUTICALS CORP [US]) [X] 1,2,7-9* page 104, paragraph 486 *;
 [XA]WO2015134334  (SUO ZUCAI [US]) [X] 1,2,7-9 * claims 16-17 * [A] 6;
 [XA]EP2977379  (IVACHTCHENKO ALEXANDRE VASILIEVICH [RU], et al) [X] 1,2,7-9 * page 17 - page 21 * [A] 6;
 [A]US2016052952  (SUO ZUCAI [US], et al) [A] 1,2,4-9 * claims 1-25 * * page 48 - page 54 *;
 [X]WO2017158621  (SPHAERA PHARMA PRIVATE LTD [IN]) [X] 1-4,7-9 * page 9; compound 1009 *;
 [A]  - MARK P WALLIS ET AL, "Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides", IL FARMACO, (19990101), vol. 54, no. 1-2, doi:10.1016/S0014-827X(98)00107-4, ISSN 0014-827X, pages 83 - 89, XP055107573 [A] 1,2,4-9 * page 85; compounds 9, 10 *

DOI:   http://dx.doi.org/10.1016/S0014-827X(98)00107-4
 [XI]  - HARI K. AKULA ET AL, "Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products", ORGANIC & BIOMOLECULAR CHEMISTRY, (20170101), vol. 15, no. 5, doi:10.1039/C6OB02334G, ISSN 1477-0520, pages 1130 - 1139, XP055631274 [X] 1,2,7-9 * page 1136; figure 5; compounds 21b, 21c, 21d * [I] 4-6

DOI:   http://dx.doi.org/10.1039/C6OB02334G
 [X]  - ZHANG ET AL, "Facile rearrangement of N^4-(@a-aminoacyl)cytidines to N-(4-cytidinyl)amino acid amides", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM , NL, (20080208), vol. 49, no. 13, doi:10.1016/J.TETLET.2008.02.015, ISSN 0040-4039, pages 2052 - 2055, XP022502896 [X] 1,2 * page 2053; compound 5h *

DOI:   http://dx.doi.org/10.1016/j.tetlet.2008.02.015
 [X]  - KRASZEWSKI A. ET AL, "Synthesis of 4-mono- and dialkyl-2'-deoxycytidines and their insertion into an oligonucleotide", TETRAHEDRON LETTERS, Amsterdam , NL, (19860101), vol. 27, no. 7, doi:10.1016/S0040-4039(00)84121-0, ISSN 0040-4039, pages 861 - 864, XP055845473 [X] 1,2 * page 862; compound IIIk *

DOI:   http://dx.doi.org/10.1016/S0040-4039(00)84121-0
 [X]  - WEBB T R ET AL, "HYRIDIZATION TRIGGERED CROSS-LINKING OF DEOXYOLIGONUCLEOTIDES", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, (19861001), vol. 14, no. 19, ISSN 0305-1048, pages 7661 - 7674, XP008035829 [X] 1,2 * page 7662; compound 1b *
 [X]  - KOMATSU HIRONORI ET AL, "An Efficient Amination Method for Manufacturing Cytidines", ORGANIC PROCESS RESEARCH & DEVELOPMENT, US, vol. 8, no. 4, doi:10.1021/op0499371, ISSN 1083-6160, (20040520), pages 564 - 567, URL: https://pubs.acs.org/doi/pdf/10.1021/op0499371, XP055845485 [X] 1,2 * page 565; compound 9 *

DOI:   http://dx.doi.org/10.1021/op0499371
International search[X]WO2015134334  (SUO ZUCAI [US]) [X] 1-9;
 [X]KR20150132879  (IVACHTCHENKO ALEXANDRE VASILIEVICH [RU], et al) [X] 1-9;
 [X]US2016052952  (SUO ZUCAI [US], et al) [X] 1-9;
 [X]  - WADA, T., "Synthesis and hybridization ability of oligodeoxyribonucleotides incorporating N-acyldeoxycytidine derivatives", European Journal of Organic Chemistry, (20010000), pages 4583 - 4593, XP002595983 [X] 1-5
 [X]  - WALLIS, M. P., "Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides", II Farmaco, (19990000), vol. 54, pages 83 - 89, XP055107573 [X] 1-9

DOI:   http://dx.doi.org/10.1016/S0014-827X(98)00107-4
 [X]  - AKULA, H. K., "Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-l-yloxy) tris (dimethylamino) phosphonium hexafluorophosphate (BOP) and biological evaluations of the products", Organic & Biomolecular Chemistry, (20170000), vol. 15, pages 1130 - 1139, XP055631274 [X] 1-9

DOI:   http://dx.doi.org/10.1039/C6OB02334G
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.